ClinicalTrials.gov
public full text
Public Domain
The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease
The IFX adherence to CD in China was not high. Medicine concerns may be predictive factor of adherence. By enhancing knowledge and relieving medicine concerns, we may increase patients' adherence to IFX.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Medication Use and Guideline Adherence in Inflammatory Bowel Disease Management: A Retrospective Study from a Tertiary Care Hospital in Pakistan (2019–2024).#244351
- Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients#901773
- Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease#1030262
- Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients#805914
- A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China#842968
Record · ID 833370
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive